1xbet 후기., Ltd.
1xbet 후기s
December 11, 2018
1xbet 후기
1xbet 후기
1xbet 후기., Ltd. today announces that its U.S.-based indirect subsidiary Avanir Pharmaceuticals, Inc. has agreed with Optinose, Inc. to return to Optinose the rights in North America to ONZETRA®Xsail® 1xbet 후기 the acute treatment of migraines in adults.
Avanir comprehensively reevaluated the U.S. migraine medication market. As a result, the decision was made to terminate the licensing agreement.
Latest 1xbet 후기 Business related News Releases